Morgan Stanley: Lowers IBM (IBM.US) target price from $293 to $190.

AstraZeneca (AZN.US) has announced the termination of its clinical trial for the experimental drug volrustomig, after recent data indicated that the drug does not appear to provide superior results to existing therapies in lung cancer treatment. The latest update from AstraZeneca’s eVOLVE-Lung02 phase III clinical trial showed that volrustomig was not more effective than the blockbuster drug Keytruda in treating patients with low PD-L1 expression metastatic non-small cell lung cancer. Both drug

Rate hike expectations ease, US dollar approaches over two-month low, gold prices edge higher on Monday

Haitong International has released a research report stating that, in the current fragmented content market flooded by AI-generated content, Bilibili's content value is increasingly prominent. It is one of the few mid- to long-form video platforms that can still maintain user growth. The robust content ecosystem is expected to drive strong growth in advertising, and coupled with steady user traffic increases, has become the platform’s competitive advantage. The firm believes Bilibili’s current

The Australian and New Zealand dollars both hit ten-week highs as easing Federal Reserve rate hike expectations continue to pressure the US dollar.